Clinical evaluation of the risk-benefit profile of biological therapies in the management of psoriatic arthritis
Psoriatic arthritis (PsA) Is a chronic autoimmune inflammatory condition that has skin and joint components. Understanding the pathophysiology of the disease has paved the way for a breakthrough in its management with the introduction of antitumour necrosis factor therapies (TNFs). However, little i...
| Main Author: | |
|---|---|
| Published: |
University of Manchester
2009
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.506253 |